APO Research
Talk to an analyst

APO RESEARCH · REPORT

IVD Reagent Clinical Trial Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global IVD Reagent Clinical Trial Services Market Outlook and Growth Opportunities 2026

1 May 2026193 pages

Choose your research edition.

Industry ResearchIVD Reagent Clinical Trial Services Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal IVD Reagent Clinical Trial Services Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal IVD Reagent Clinical Trial Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IVD Reagent Clinical Trial Services Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal IVD Reagent Clinical Trial Services Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global IVD Reagent Clinical Trial Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for IVD Reagent Clinical Trial Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for IVD Reagent Clinical Trial Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IVD Reagent Clinical Trial Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the IVD Reagent Clinical Trial Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the IVD Reagent Clinical Trial Services market include IQVIA, ICON plc, Labcorp, NAMSA, Parexel, Medpace, Fortrea, Quest Diagnostics and Avania, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global IVD Reagent Clinical Trial Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of IVD Reagent Clinical Trial Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents IVD Reagent Clinical Trial Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global IVD Reagent Clinical Trial Services market.

IVD Reagent Clinical Trial Services Segment by Company

IQVIA

ICON plc

Labcorp

NAMSA

Parexel

Medpace

Fortrea

Quest Diagnostics

Avania

Hangzhou Tigermed Consulting

Eurofins Scientific

Cerba Research

ClinChoice

CMIC Group

Syneos Health

ResearchDx

Premier Research

Quanticate

SGS

Guangzhou Jinmanli Pharmaceutical Technology

WuXi AppTec

IVD Reagent Clinical Trial Services Segment by Type

Early-Stage Clinical Trials (Phase I)

Late-Stage Clinical Trials (Phase III)

IVD Reagent Clinical Trial Services Segment by Application

Early Cancer Screening

Infectious Disease Testing

Genetic Disease Diagnosis

Other

IVD Reagent Clinical Trial Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global IVD Reagent Clinical Trial Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the IVD Reagent Clinical Trial Services key companies, revenue, market share, and recent developments.

3. To split the IVD Reagent Clinical Trial Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions IVD Reagent Clinical Trial Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify IVD Reagent Clinical Trial Services significant trends, drivers, influence factors in global and regions.

6. To analyze IVD Reagent Clinical Trial Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVD Reagent Clinical Trial Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IVD Reagent Clinical Trial Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVD Reagent Clinical Trial Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global IVD Reagent Clinical Trial Services industry.

Chapter 3: Detailed analysis of IVD Reagent Clinical Trial Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of IVD Reagent Clinical Trial Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of IVD Reagent Clinical Trial Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. IVD Reagent Clinical Trial Services Industry Trends Table 2. IVD Reagent Clinical Trial Services Industry Drivers Table 3. IVD Reagent Clinical Trial Services Industry Opportunities and Challenges Table 4. IVD Reagent Clinical Trial Services Industry Restraints Table 5. Global IVD Reagent Clinical Trial Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global IVD Reagent Clinical Trial Services Revenue Share by Company (2021-2026) Table 7. Global IVD Reagent Clinical Trial Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global IVD Reagent Clinical Trial Services Key Company Manufacturing Base & Headquarters Table 9. Global IVD Reagent Clinical Trial Services Company, Product Type & Application Table 10. Global IVD Reagent Clinical Trial Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global IVD Reagent Clinical Trial Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Early-Stage Clinical Trials (Phase I) Table 15. Significant Companies of Late-Stage Clinical Trials (Phase III) Table 16. Global IVD Reagent Clinical Trial Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global IVD Reagent Clinical Trial Services Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global IVD Reagent Clinical Trial Services Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global IVD Reagent Clinical Trial Services Sales Value Share by Type (2021-2026) Table 20. Global IVD Reagent Clinical Trial Services Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Early Cancer Screening Table 22. Significant Companies of Infectious Disease Testing Table 23. Significant Companies of Genetic Disease Diagnosis Table 24. Significant Companies of Other Table 25. Global IVD Reagent Clinical Trial Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global IVD Reagent Clinical Trial Services Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global IVD Reagent Clinical Trial Services Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global IVD Reagent Clinical Trial Services Sales Value Share by Application (2021-2026) Table 29. Global IVD Reagent Clinical Trial Services Sales Value Share by Application (2027-2032) Table 30. Global IVD Reagent Clinical Trial Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global IVD Reagent Clinical Trial Services Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global IVD Reagent Clinical Trial Services Sales Value Share by Region (2021-2026) Table 33. Global IVD Reagent Clinical Trial Services Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global IVD Reagent Clinical Trial Services Sales Value Share by Region (2027-2032) Table 35. Global IVD Reagent Clinical Trial Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global IVD Reagent Clinical Trial Services Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global IVD Reagent Clinical Trial Services Sales Value Market Share by Country (2021-2026) Table 38. Global IVD Reagent Clinical Trial Services Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global IVD Reagent Clinical Trial Services Sales Value Market Share by Country (2027-2032) Table 40. IQVIA Company Information Table 41. IQVIA Business Overview Table 42. IQVIA IVD Reagent Clinical Trial Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. IQVIA IVD Reagent Clinical Trial Services Product Portfolio Table 44. IQVIA Recent Development Table 45. ICON plc Company Information Table 46. ICON plc Business Overview Table 47. ICON plc IVD Reagent Clinical Trial Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. ICON plc IVD Reagent Clinical Trial Services Product Portfolio Table 49. ICON plc Recent Development Table 50. Labcorp Company Information Table 51. Labcorp Business Overview Table 52. Labcorp IVD Reagent Clinical Trial Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Labcorp IVD Reagent Clinical Trial Services Product Portfolio Table 54. Labcorp Recent Development Table 55. NAMSA Company Information Table 56. NAMSA Business Overview Table 57. NAMSA IVD Reagent Clinical Trial Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. NAMSA IVD Reagent Clinical Trial Services Product Portfolio Table 59. NAMSA Recent Development Table 60. Parexel Company Information Table 61. Parexel Business Overview Table 62. Parexel IVD Reagent Clinical Trial Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Parexel IVD Reagent Clinical Trial Services Product Portfolio Table 64. Parexel Recent Development Table 65. Medpace Company Information Table 66. Medpace Business Overview Table 67. Medpace IVD Reagent Clinical Trial Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Medpace IVD Reagent Clinical Trial Services Product Portfolio Table 69. Medpace Recent Development Table 70. Fortrea Company Information Table 71. Fortrea Business Overview Table 72. Fortrea IVD Reagent Clinical Trial Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Fortrea IVD Reagent Clinical Trial Services Product Portfolio Table 74. Fortrea Recent Development Table 75. Quest Diagnostics Company Information Table 76. Quest Diagnostics Business Overview Table 77. Quest Diagnostics IVD Reagent Clinical Trial Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Quest Diagnostics IVD Reagent Clinical Trial Services Product Portfolio Table 79. Quest Diagnostics Recent Development Table 80. Avania Company Information Table 81. Avania Business Overview Table 82. Avania IVD Reagent Clinical Trial Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Avania IVD Reagent Clinical Trial Services Product Portfolio Table 84. Avania Recent Development Table 85. Hangzhou Tigermed Consulting Company Information Table 86. Hangzhou Tigermed Consulting Business Overview Table 87. Hangzhou Tigermed Consulting IVD Reagent Clinical Trial Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Hangzhou Tigermed Consulting IVD Reagent Clinical Trial Services Product Portfolio Table 89. Hangzhou Tigermed Consulting Recent Development Table 90. Eurofins Scientific Company Information Table 91. Eurofins Scientific Business Overview Table 92. Eurofins Scientific IVD Reagent Clinical Trial Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Eurofins Scientific IVD Reagent Clinical Trial Services Product Portfolio Table 94. Eurofins Scientific Recent Development Table 95. Cerba Research Company Information Table 96. Cerba Research Business Overview Table 97. Cerba Research IVD Reagent Clinical Trial Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Cerba Research IVD Reagent Clinical Trial Services Product Portfolio Table 99. Cerba Research Recent Development Table 100. ClinChoice Company Information Table 101. ClinChoice Business Overview Table 102. ClinChoice IVD Reagent Clinical Trial Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. ClinChoice IVD Reagent Clinical Trial Services Product Portfolio Table 104. ClinChoice Recent Development Table 105. CMIC Group Company Information Table 106. CMIC Group Business Overview Table 107. CMIC Group IVD Reagent Clinical Trial Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. CMIC Group IVD Reagent Clinical Trial Services Product Portfolio Table 109. CMIC Group Recent Development Table 110. Syneos Health Company Information Table 111. Syneos Health Business Overview Table 112. Syneos Health IVD Reagent Clinical Trial Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Syneos Health IVD Reagent Clinical Trial Services Product Portfolio Table 114. Syneos Health Recent Development Table 115. ResearchDx Company Information Table 116. ResearchDx Business Overview Table 117. ResearchDx IVD Reagent Clinical Trial Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. ResearchDx IVD Reagent Clinical Trial Services Product Portfolio Table 119. ResearchDx Recent Development Table 120. Premier Research Company Information Table 121. Premier Research Business Overview Table 122. Premier Research IVD Reagent Clinical Trial Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Premier Research IVD Reagent Clinical Trial Services Product Portfolio Table 124. Premier Research Recent Development Table 125. Quanticate Company Information Table 126. Quanticate Business Overview Table 127. Quanticate IVD Reagent Clinical Trial Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Quanticate IVD Reagent Clinical Trial Services Product Portfolio Table 129. Quanticate Recent Development Table 130. SGS Company Information Table 131. SGS Business Overview Table 132. SGS IVD Reagent Clinical Trial Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. SGS IVD Reagent Clinical Trial Services Product Portfolio Table 134. SGS Recent Development Table 135. Guangzhou Jinmanli Pharmaceutical Technology Company Information Table 136. Guangzhou Jinmanli Pharmaceutical Technology Business Overview Table 137. Guangzhou Jinmanli Pharmaceutical Technology IVD Reagent Clinical Trial Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Guangzhou Jinmanli Pharmaceutical Technology IVD Reagent Clinical Trial Services Product Portfolio Table 139. Guangzhou Jinmanli Pharmaceutical Technology Recent Development Table 140. WuXi AppTec Company Information Table 141. WuXi AppTec Business Overview Table 142. WuXi AppTec IVD Reagent Clinical Trial Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. WuXi AppTec IVD Reagent Clinical Trial Services Product Portfolio Table 144. WuXi AppTec Recent Development Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. IVD Reagent Clinical Trial Services Product Image Figure 2. Global IVD Reagent Clinical Trial Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IVD Reagent Clinical Trial Services Market Size (2021-2032) & (US$ Million) Figure 4. Global IVD Reagent Clinical Trial Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Early-Stage Clinical Trials (Phase I) Image Figure 8. Late-Stage Clinical Trials (Phase III) Image Figure 9. Global IVD Reagent Clinical Trial Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global IVD Reagent Clinical Trial Services Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global IVD Reagent Clinical Trial Services Sales Value Share by Type (2021-2032) Figure 12. Early Cancer Screening Image Figure 13. Infectious Disease Testing Image Figure 14. Genetic Disease Diagnosis Image Figure 15. Other Image Figure 16. Global IVD Reagent Clinical Trial Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global IVD Reagent Clinical Trial Services Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global IVD Reagent Clinical Trial Services Sales Value Share by Application (2021-2032) Figure 19. Global IVD Reagent Clinical Trial Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global IVD Reagent Clinical Trial Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America IVD Reagent Clinical Trial Services Sales Value (2021-2032) & (US$ Million) Figure 22. North America IVD Reagent Clinical Trial Services Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe IVD Reagent Clinical Trial Services Sales Value (2021-2032) & (US$ Million) Figure 24. Europe IVD Reagent Clinical Trial Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific IVD Reagent Clinical Trial Services Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific IVD Reagent Clinical Trial Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America IVD Reagent Clinical Trial Services Sales Value (2021-2032) & (US$ Million) Figure 28. South America IVD Reagent Clinical Trial Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa IVD Reagent Clinical Trial Services Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa IVD Reagent Clinical Trial Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Early-Stage Clinical Trials (Phase I)
  • Late-Stage Clinical Trials (Phase III)
Applications
  • Early Cancer Screening
  • Infectious Disease Testing
  • Genetic Disease Diagnosis
  • Other
Companies covered
  • IQVIA
  • ICON plc
  • Labcorp
  • NAMSA
  • Parexel
  • Medpace
  • Fortrea
  • Quest Diagnostics
  • Avania
  • Hangzhou Tigermed Consulting
  • Eurofins Scientific
  • Cerba Research
  • ClinChoice
  • CMIC Group
  • Syneos Health
  • ResearchDx
  • Premier Research
  • Quanticate
  • SGS
  • Guangzhou Jinmanli Pharmaceutical Technology
  • WuXi AppTec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global IVD Reagent Clinical Trial Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global IVD Reagent Clinical Trial Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 IVD Reagent Clinical Trial Services Market Dynamics
  1. 2.1 IVD Reagent Clinical Trial Services Industry Trends
  2. 2.2 IVD Reagent Clinical Trial Services Industry Drivers
  3. 2.3 IVD Reagent Clinical Trial Services Industry Opportunities and Challenges
  4. 2.4 IVD Reagent Clinical Trial Services Industry Restraints
3 IVD Reagent Clinical Trial Services Market by Company
  1. 3.1 Global IVD Reagent Clinical Trial Services Company Revenue Ranking in 2025
  2. 3.2 Global IVD Reagent Clinical Trial Services Revenue by Company (2021-2026)
  3. 3.3 Global IVD Reagent Clinical Trial Services Company Ranking (2024-2026)
  4. 3.4 Global IVD Reagent Clinical Trial Services Company Manufacturing Base and Headquarters
  5. 3.5 Global IVD Reagent Clinical Trial Services Company Product Type and Application
  6. 3.6 Global IVD Reagent Clinical Trial Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global IVD Reagent Clinical Trial Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 IVD Reagent Clinical Trial Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 IVD Reagent Clinical Trial Services Market by Type
  1. 4.1 IVD Reagent Clinical Trial Services Type Introduction
  2. 4.1.1 Early-Stage Clinical Trials (Phase I)
  3. 4.1.2 Late-Stage Clinical Trials (Phase III)
  4. 4.2 Global IVD Reagent Clinical Trial Services Sales Value by Type
  5. 4.2.1 Global IVD Reagent Clinical Trial Services Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global IVD Reagent Clinical Trial Services Sales Value by Type (2021-2032)
  7. 4.2.3 Global IVD Reagent Clinical Trial Services Sales Value Share by Type (2021-2032)
5 IVD Reagent Clinical Trial Services Market by Application
  1. 5.1 IVD Reagent Clinical Trial Services Application Introduction
  2. 5.1.1 Early Cancer Screening
  3. 5.1.2 Infectious Disease Testing
  4. 5.1.3 Genetic Disease Diagnosis
  5. 5.1.4 Other
  6. 5.2 Global IVD Reagent Clinical Trial Services Sales Value by Application
  7. 5.2.1 Global IVD Reagent Clinical Trial Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global IVD Reagent Clinical Trial Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global IVD Reagent Clinical Trial Services Sales Value Share by Application (2021-2032)
6 IVD Reagent Clinical Trial Services Regional Value Analysis
  1. 6.1 Global IVD Reagent Clinical Trial Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global IVD Reagent Clinical Trial Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global IVD Reagent Clinical Trial Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global IVD Reagent Clinical Trial Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America IVD Reagent Clinical Trial Services Sales Value (2021-2032)
  7. 6.3.2 North America IVD Reagent Clinical Trial Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe IVD Reagent Clinical Trial Services Sales Value (2021-2032)
  10. 6.4.2 Europe IVD Reagent Clinical Trial Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific IVD Reagent Clinical Trial Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific IVD Reagent Clinical Trial Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America IVD Reagent Clinical Trial Services Sales Value (2021-2032)
  16. 6.6.2 South America IVD Reagent Clinical Trial Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa IVD Reagent Clinical Trial Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa IVD Reagent Clinical Trial Services Sales Value Share by Country, 2025 VS 2032
7 IVD Reagent Clinical Trial Services Country-level Value Analysis
  1. 7.1 Global IVD Reagent Clinical Trial Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global IVD Reagent Clinical Trial Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global IVD Reagent Clinical Trial Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global IVD Reagent Clinical Trial Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt IVD Reagent Clinical Trial Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt IVD Reagent Clinical Trial Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt IVD Reagent Clinical Trial Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 IQVIA
  2. 8.1.1 IQVIA Company Information
  3. 8.1.2 IQVIA Business Overview
  4. 8.1.3 IQVIA IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 IQVIA IVD Reagent Clinical Trial Services Product Portfolio
  6. 8.1.5 IQVIA Recent Developments
  7. 8.2 ICON plc
  8. 8.2.1 ICON plc Company Information
  9. 8.2.2 ICON plc Business Overview
  10. 8.2.3 ICON plc IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ICON plc IVD Reagent Clinical Trial Services Product Portfolio
  12. 8.2.5 ICON plc Recent Developments
  13. 8.3 Labcorp
  14. 8.3.1 Labcorp Company Information
  15. 8.3.2 Labcorp Business Overview
  16. 8.3.3 Labcorp IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Labcorp IVD Reagent Clinical Trial Services Product Portfolio
  18. 8.3.5 Labcorp Recent Developments
  19. 8.4 NAMSA
  20. 8.4.1 NAMSA Company Information
  21. 8.4.2 NAMSA Business Overview
  22. 8.4.3 NAMSA IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NAMSA IVD Reagent Clinical Trial Services Product Portfolio
  24. 8.4.5 NAMSA Recent Developments
  25. 8.5 Parexel
  26. 8.5.1 Parexel Company Information
  27. 8.5.2 Parexel Business Overview
  28. 8.5.3 Parexel IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Parexel IVD Reagent Clinical Trial Services Product Portfolio
  30. 8.5.5 Parexel Recent Developments
  31. 8.6 Medpace
  32. 8.6.1 Medpace Company Information
  33. 8.6.2 Medpace Business Overview
  34. 8.6.3 Medpace IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medpace IVD Reagent Clinical Trial Services Product Portfolio
  36. 8.6.5 Medpace Recent Developments
  37. 8.7 Fortrea
  38. 8.7.1 Fortrea Company Information
  39. 8.7.2 Fortrea Business Overview
  40. 8.7.3 Fortrea IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fortrea IVD Reagent Clinical Trial Services Product Portfolio
  42. 8.7.5 Fortrea Recent Developments
  43. 8.8 Quest Diagnostics
  44. 8.8.1 Quest Diagnostics Company Information
  45. 8.8.2 Quest Diagnostics Business Overview
  46. 8.8.3 Quest Diagnostics IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Quest Diagnostics IVD Reagent Clinical Trial Services Product Portfolio
  48. 8.8.5 Quest Diagnostics Recent Developments
  49. 8.9 Avania
  50. 8.9.1 Avania Company Information
  51. 8.9.2 Avania Business Overview
  52. 8.9.3 Avania IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Avania IVD Reagent Clinical Trial Services Product Portfolio
  54. 8.9.5 Avania Recent Developments
  55. 8.10 Hangzhou Tigermed Consulting
  56. 8.10.1 Hangzhou Tigermed Consulting Company Information
  57. 8.10.2 Hangzhou Tigermed Consulting Business Overview
  58. 8.10.3 Hangzhou Tigermed Consulting IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hangzhou Tigermed Consulting IVD Reagent Clinical Trial Services Product Portfolio
  60. 8.10.5 Hangzhou Tigermed Consulting Recent Developments
  61. 8.11 Eurofins Scientific
  62. 8.11.1 Eurofins Scientific Company Information
  63. 8.11.2 Eurofins Scientific Business Overview
  64. 8.11.3 Eurofins Scientific IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Eurofins Scientific IVD Reagent Clinical Trial Services Product Portfolio
  66. 8.11.5 Eurofins Scientific Recent Developments
  67. 8.12 Cerba Research
  68. 8.12.1 Cerba Research Company Information
  69. 8.12.2 Cerba Research Business Overview
  70. 8.12.3 Cerba Research IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cerba Research IVD Reagent Clinical Trial Services Product Portfolio
  72. 8.12.5 Cerba Research Recent Developments
  73. 8.13 ClinChoice
  74. 8.13.1 ClinChoice Company Information
  75. 8.13.2 ClinChoice Business Overview
  76. 8.13.3 ClinChoice IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ClinChoice IVD Reagent Clinical Trial Services Product Portfolio
  78. 8.13.5 ClinChoice Recent Developments
  79. 8.14 CMIC Group
  80. 8.14.1 CMIC Group Company Information
  81. 8.14.2 CMIC Group Business Overview
  82. 8.14.3 CMIC Group IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CMIC Group IVD Reagent Clinical Trial Services Product Portfolio
  84. 8.14.5 CMIC Group Recent Developments
  85. 8.15 Syneos Health
  86. 8.15.1 Syneos Health Company Information
  87. 8.15.2 Syneos Health Business Overview
  88. 8.15.3 Syneos Health IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Syneos Health IVD Reagent Clinical Trial Services Product Portfolio
  90. 8.15.5 Syneos Health Recent Developments
  91. 8.16 ResearchDx
  92. 8.16.1 ResearchDx Company Information
  93. 8.16.2 ResearchDx Business Overview
  94. 8.16.3 ResearchDx IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ResearchDx IVD Reagent Clinical Trial Services Product Portfolio
  96. 8.16.5 ResearchDx Recent Developments
  97. 8.17 Premier Research
  98. 8.17.1 Premier Research Company Information
  99. 8.17.2 Premier Research Business Overview
  100. 8.17.3 Premier Research IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Premier Research IVD Reagent Clinical Trial Services Product Portfolio
  102. 8.17.5 Premier Research Recent Developments
  103. 8.18 Quanticate
  104. 8.18.1 Quanticate Company Information
  105. 8.18.2 Quanticate Business Overview
  106. 8.18.3 Quanticate IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Quanticate IVD Reagent Clinical Trial Services Product Portfolio
  108. 8.18.5 Quanticate Recent Developments
  109. 8.19 SGS
  110. 8.19.1 SGS Company Information
  111. 8.19.2 SGS Business Overview
  112. 8.19.3 SGS IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 SGS IVD Reagent Clinical Trial Services Product Portfolio
  114. 8.19.5 SGS Recent Developments
  115. 8.20 Guangzhou Jinmanli Pharmaceutical Technology
  116. 8.20.1 Guangzhou Jinmanli Pharmaceutical Technology Company Information
  117. 8.20.2 Guangzhou Jinmanli Pharmaceutical Technology Business Overview
  118. 8.20.3 Guangzhou Jinmanli Pharmaceutical Technology IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Guangzhou Jinmanli Pharmaceutical Technology IVD Reagent Clinical Trial Services Product Portfolio
  120. 8.20.5 Guangzhou Jinmanli Pharmaceutical Technology Recent Developments
  121. 8.21 WuXi AppTec
  122. 8.21.1 WuXi AppTec Company Information
  123. 8.21.2 WuXi AppTec Business Overview
  124. 8.21.3 WuXi AppTec IVD Reagent Clinical Trial Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 WuXi AppTec IVD Reagent Clinical Trial Services Product Portfolio
  126. 8.21.5 WuXi AppTec Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst